These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 13890494)
1. [Aldosterone therapy in congenital salt-losing syndrome. A case report contribution]. ERCHE G Z Kinderheilkd; 1961; 86():217-32. PubMed ID: 13890494 [No Abstract] [Full Text] [Related]
2. [The salt-losing syndrome in the course of congenital adrenal virlizing hyperplasia]. RAPPAPORT R Fr Med; 1962 Jan; 25():11-9. PubMed ID: 14490384 [No Abstract] [Full Text] [Related]
4. Presence of an aldosterone stimulating substance in the urine of rats deprived of salt. ORTI E; RALLI EP; LAKEN B; DUMM ME Am J Physiol; 1957 Nov; 191(2):323-8. PubMed ID: 13478736 [No Abstract] [Full Text] [Related]
5. [Effect of salt diuretic substances on urinary excretion of aldosterone]. ROMANI JD Ann Endocrinol (Paris); 1961; 22():239-47. PubMed ID: 13743000 [No Abstract] [Full Text] [Related]
6. [Salt wasting syndrome caused by congenital, insufficient synthesis or aldosterone function--etiology, diagnosis and management]. Basiak A; Wikiera B; Noczyńska A Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):103-8. PubMed ID: 15996340 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone. DAVIS JO Am J Med; 1960 Sep; 29():486-507. PubMed ID: 13720203 [No Abstract] [Full Text] [Related]
8. Effects of an acute salt load in a case of primary hyperaldo-steronism before and nine months after surgical cure: comparison with normal subjects and patients with essential hypertension before and after reduction of their elevated pressure with drug treatment. ORTUZAR R; CROXATTO R; THOMSEN P; GONZALEZ J J Lab Clin Med; 1959 Nov; 54():712-21. PubMed ID: 14429166 [No Abstract] [Full Text] [Related]
9. [Physiopathology of the salt-losing syndrome during congenital adrenal hyperplasia related to a 21-hydroxylation defect]. Rappaport R Ann Pediatr (Paris); 1965 Dec; 12(12):807-8. PubMed ID: 5854043 [No Abstract] [Full Text] [Related]
10. [Effects of the prolonged administration of aldosterone. Antagonistic action of glucocorticoids on the water-salt retention of aldosterone]. LENZI S; AGNOLI GC; CARIANI A; LODI A; PINELLI G Boll Soc Ital Biol Sper; 1962 Mar; 38():241-6. PubMed ID: 14464047 [No Abstract] [Full Text] [Related]
11. [ON THE THERAPY OF THE CONGENITAL SALT-LOSS SYNDROME WITH ALDOSTERONE]. TAHBASIAN M Monatsschr Kinderheilkd (1902); 1963 Nov; 111():416-21. PubMed ID: 14097708 [No Abstract] [Full Text] [Related]
12. Salt losing syndrome in nephropathy: cases of salt losing nephritis, one with extensive soft tissue calcification. ERICSON E; SVANBORG A Acta Med Scand; 1956 Jan; 153(4):283-91. PubMed ID: 13301459 [No Abstract] [Full Text] [Related]
13. SWEAT CHLORIDES IN SALT-DEPRIVED CYSTIC FIBROSIS HETEROZYGOTES. MYERS MF Can Med Assoc J; 1965 Apr; 92(17):926-7. PubMed ID: 14289142 [TBL] [Abstract][Full Text] [Related]
14. [SENSITIVITY TO ALDOSTERONE OF POLYURIA AND SALT-LOSING OBSERVED DURING AN ANURIC EPISODE]. LAMBERT PP; VERNIORY A J Urol Nephrol (Paris); 1963; 69():628-31. PubMed ID: 14094280 [No Abstract] [Full Text] [Related]